Q35* (p.Gln35Ter) variant of PON1 (Serum paraoxonase/arylesterase 1)
Q35* (p.Gln35Ter) in PON1 (Serum paraoxonase/arylesterase 1) is a protein-truncating change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes population frequency data and structural context.
Q35* (p.Gln35Ter) variant details
- p.Gln35Ter
- TOPMed rs1193411891
- gnomAD rs1193411891
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.307
- CADD 32.00
- Most common in the Ashkenazi Jewish population (allele frequency 0.00058)
- Structural context available